Poster Abstract Session:
47. Antimicrobial Resistance: Clinical Studies
Friday, October 21, 2011: 12:15 PM-2:15 PM
Room: Poster Hall B1

Learning Objectives:

-

Target Audience: Academicians

Topical Category: A. Antimicrobial agents and Resistance

Tracks: Adult ID, Pediatric ID

Presentations:

202
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals: CANWARD 2007-2010
Andrew Walkty, MD ; Melanie Baxter, MSc ; Heather J. Adam, PhD ; Kim Nichol, MSc ; James Karlowsky, PhD ; Daryl J. Hoban, PhD ; George G. Zhanel, PhD

203
Decreased fluoroquinolone susceptibility in Salmonella Typhi and non-typhoid Salmonella isolates from bloodstream infections in Peru
Coralith Garcia ; Gabriela Goyoneche ; Lizeth Astocondor ; Gertrudis Horna, Lic MT ; Elba Linares, MD ; Rafael Ramirez, MD ; Aida Palacios ; Jorge Velasquez, MD ; Veronica Medina, MD ; Martha Urbina, MSc ; Jose Guevara, MD ; Silvia Zevallos ; Elizeth Sierra ; Frine Samalvides, MD ; Jan Jacobs, PhD

207
Risk Factors for Linezolid (LZD) and Vancomycin-Resistant Enterococci: a Case-Case Control Study
Kayoko Hayakawa, MD, PhD ; Dror Marchaim, MD ; Jason Pogue, PharmD ; Bharath Sunkara, MD ; Kevin Ho, MS ; Kavyashri Kodlipet Jagadeesh, MD ; Srinivasa Kamatam, MD ; Shakila Parveen, MD ; Priyanka Nanjireddy, MD ; Vicki Collins, MD ; Paul Lephart, PhD ; Emily Martin, MPH, PhD ; Michael Rybak, PharmD, MPH ; Keith Kaye, MD, MPH, FIDSA

208
A Multicenter Study of the Epidemiology of Colistin and Carbapenem Resistant Klebsiella pneumoniae; a preponderance of ST-258
Odaliz Abreu-Lanfranco, MD ; Dror Marchaim, MD ; David van Duin, MD, PhD ; Federico Perez, MD ; Steve Marshall, MD ; Kayoko Hayakawa, MD, PhD ; Paul Lephart, PhD ; Geraldine Hall, PhD ; Michael Jacobs, MD ; Robert Bonomo, MD ; Keith Kaye, MD, MPH, FIDSA

210
Vancomycin- and Daptomycin-Resistant Enterococcus faecium Bacteremia and Colonization in Leukemic Patients with Prolonged Neutropenia
Niraj Jani ; Rod Quilitz, PharmD ; Ana Velez, MD ; Ramon Sandin, MD ; Dawn Ruge, BS ; John Greene, MD

212
Increasing frequency of multi-resistance Pseudomonas aeruginosa in critical patients in Colombia
Lina Villa, MD ; Jorge Cortes, MD ; Aura Leal, MSc MD ; Andres Meneses, MD

213
Intravenous Colistin for Multidrug Resistent Gram Negative Bacteria in Pediatric Patients
Pia Pannaraj, MD, MPH ; Jim Hung, BS ; Hailin Wang, MPH ; Melanie George

214
Clinical implication of extended-spectrum cephalosporin resistance in Streptococcus pneumoniae meningitis
Seong-Ho Choi, M. D. ; Jin-Won Chung ; Baek-Nam Kim ; Yee Gyung Kwak, MD ; Tae Hyong Kim, MD ; Eun Jung Lee, MD ; Eun Ju Choo, MD ; Min Hyok Jeon, MD ; Mi Suk Lee, MD ; In-Gyu Bae, MD ; Sang-Rok Lee ; Eun Hee Song ; Jae-Bum Jun ; Mi-Na Kim, MD, PhD ; Sung-Han Kim, MD, PhD ; Sang-Oh Lee, MD ; Yang Soo Kim, MD, PhD ; Jun Hee Woo, MD, PhD ; Sang-Ho Choi, MD, PhD

215
Oral Fosfomycin in the Treatment of Vancomycin-Resistant Enterococcal Urinary Tract Infections
Christy Varughese, PharmD ; Eric Tichy, PharmD ; Jeffrey Topal, MD

216
High Loading Doses of Vancomycin (≥ 25 mg/kg) are Associated with an Increased Incidence of Nephrotoxicity
David K. Hwang, PharmD, PhD ; Travis B. Dick, PharmD, BCPS ; Paul Wohlt, PharmD, BCPS ; Elizabeth Sebranek-Evans, PharmD, BCPS, CGP

217
Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae : A Case-Control Study
So Yeon Park, MD ; Cheol-In Kang, MD ; Min Hee Lim, MD ; Hyun Ah Kim ; Eun-Jeong Joo, MD ; Young Eun Ha, MD ; Doo Ryeon Chung, MD ; Kyong Ran Peck, MD ; Jae-Hoon Song, MD

218
Persistence Pays: Prolonged Carriage of Plasmid-Borne Broad-Spectrum Β-Lactam Resistant Enterobacteriaceae
Amanda Adler, BA ; Xuan Qin, PhD ; Scott Weissman, MD ; Danielle Zerr, MD, MPH

222
Trends in E. coli and K. pneumoniae ESBL Rates in Urinary Tract Infections – TEST 2004-2010
Samuel Bouchillon, MD ; Meredith Hackel, PhD ; Stephen Hawser, PhD ; Brian Johnson, BS ; Daryl Hoban, PhD ; Michael Dowzicky, MS

223
Piperacillin/Tazobactam (PT) in the Treatment of Extended Spectrum beta-Lactamase (ESBL) Producing Bacterial Infections
Elizabeth Bankstahl, MD ; Susan Szpunar, PhD ; Laurence Briski, MD ; Joel Fishbain, MD

224
Risk Factors for Extended-Spectrum Beta-Lactamase Producing Organisms: A Case-Case-Control Study
Mohamad Yasmin ; Tania Baban ; Souha Kanj ; Rima Hanna Wakim ; George Araj ; Ghassan Matar ; Ghassan Dbaibo ; Zeina Kanafani

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.